Source: Annual Congress 2002 - Pulmonary hypertension
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. M. Fellrath, R. Lemoine, J. D. Aubert (Lausanne, Switzerland). Lung involvement distinct from pulmonary hypertension: a new feature of POEMS syndrome. Eur Respir J 2002; 20: Suppl. 38, 2315

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary involvement in antisynthetase syndrome: more than myopathy Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases Year: 2021 Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival Source: Eur Respir J 2013; 42: 1271-1282 Year: 2013 Lung abnormalities in marfan syndrome: a pathogenetic model of early-onset emphysema? Source: Annual Congress 2009 - Respiratory physiology Year: 2009 Portopulmonary hypertension: a further clue to pathogenesis? Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension Year: 2005 Pulmonary involvement in patients with Marfan syndrome Source: Annual Congress 2012 - Pulmonary manifestations of systemic diseases Year: 2012 Pulmonary involvement in Marfan syndrome Source: International Congress 2018 – Management of chronic cough and respiratory muscle dysfunction Year: 2018 Castleman disease variant of atypical POEMS syndrome: A case presentatIon Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014 Prolidase deficiency: a new genetic cause of combined pulmonary fibrosis and emphysema syndrome in the adult Source: Eur Respir J, 55 (4) 1901952; 10.1183/13993003.01952-2019 Year: 2020 Early pulmonary phenotype in Hermansky-Pudlak syndrome: Analysis of the chILD-EU registry Source: International Congress 2016 – Paediatric bronchology I Year: 2016 Antisynthetase syndrome related interstitial lung disease may have a better treatment response than other forms of Idiopathic Inflammatory Myopathies: a multi-national study Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 The metabolic syndrome and pulmonary hypertension Source: Virtual Congress 2020 – Pulmonary vascular diseases Year: 2020 Nephrotic syndrome associated with pulmonary tuberculosis – case presentation Source: Eur Respir J 2007; 30: Suppl. 51, 88s Year: 2007 Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? Source: Eur Respir J 2007; 30: 835-839 Year: 2007 TBX4 syndrome: a systemic disease highlighted by pulmonary arterial hypertension in its most severe form Source: Eur Respir J, 55 (5) 2000585; 10.1183/13993003.00585-2020 Year: 2020 Idiopathic pulmonary fibrosis phenotypes: Identification of new clinico-pathological stigmata Source: Annual Congress 2010 - Clinical issues in idiopathic pulmonary fibrosis Year: 2010 Combined pulmonary fibrosis and emphysema: A distinct entity? Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Pulmonary hypertension: a paradigm for rare pulmonary diseases Source: Eur Respir Rev, 26 (146) 170120; 10.1183/16000617.0120-2017 Year: 2017 Chronic thromboembolic pulmonary hypertension: a distinct disease entity Source: Eur Respir Rev 2015; 24: 246-252 Year: 2015 Prognostic significance of selected biomarkers in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease Source: International Congress 2014 – Sarcoidosis Year: 2014